Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.79 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.65 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872599 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL8728931 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL7942033 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL536128 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL714530 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL6635175 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL20956609 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL20956606 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL20956594 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL20956593 | 1.00 | NOD1 (0.79) | NOD1PLA2G2CPLA2G10SLC6A5FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025069444-A1 | WATER-IN-OIL EMULSIFIED COSMETIC OR ANHYDROUS COSMETIC AND METHOD FOR THEIR PRODUCTION | LVMH RECHERCHE (FR) | 2025-04-03 | — | — | WO | claimed |
| CN-118222361-A | Strong-effect antibacterial clothes cleaning agent and preparation method and application thereof | 广东莱雅新化工科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| WO-2024116413-A1 | POWDER COSMETIC COMPOSITION | LVMH RECHERCHE (FR) | 2024-06-06 | — | — | WO | claimed |
| CN-117779004-A | Presoaked liquid for ionic palladium activation process and application method thereof | 广东哈福技术股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115197432-B | Antibacterial/antiviral polymer material and preparation method thereof | 中国科学院长春应用化学研究所 | 2024-03-26 | — | — | CN | claimed |
| US-20240050560-A1 | SELF-SUSTAINED RELEASE IMMUNE ADJUVANT SUSPENSION, PREPARATION METHOD THEREFOR, AND USE THEREOF | INNOBM PHARMACEUTICALS CO., LTD. (CN) | 2024-02-15 | — | — | US | claimed |
| CN-117402665-A | Antibacterial composite calcium sulfonate lubricating grease composition and preparation method thereof | 中国石油化工股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-113271774-B | Synergistic disinfectant compositions with enhanced antimicrobial efficacy and stability and methods of use thereof | 戴弗西公司 | 2024-01-12 | — | — | CN | claimed |
| US-20230372217-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2023-11-23 | — | — | US | claimed |
| US-11820853-B2 | Impact-resistant and aging-resistant reflective plastic applied to automobiles | Shenzhen Jinzhicheng Plastic Technology Co., Ltd. (CN) | 2023-11-21 | — | — | US | claimed |
| US-9642790-B2 | Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof | VIVATECH (FR) | 2017-05-09 | — | — | US | claimed |
| WO-2017060500-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | CYPRUMED GMBH (AT) | 2017-04-13 | — | — | WO | claimed |
| EP-3006045-B1 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | CYPRUMED GMBH (AT) | 2017-04-12 | — | — | EP | claimed |
| WO-2016055550-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS | CYPRUMED GMBH (AT) | 2016-04-14 | — | — | WO | claimed |
| EP-3006045-A1 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | Cyprumed GmbH (AT) | 2016-04-13 | — | — | EP | claimed |
| US-20150174042-A1 | AQUEOUS DISPERSION OF POLYMER PARTICLES, FILM-FORMING COMPOSITION CONTAINING SAME AND USES THEREOF | VIVATECH (FR) | 2015-06-25 | — | — | US | claimed |
| US-20140056953-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2014-02-27 | — | — | US | claimed |
| US-8658139-B1 | Prevention and treatment of oral diseases | SQUIGLE, INC. (US) | 2014-02-25 | — | — | US | claimed |
| US-20120321576-A1 | SUNSCREEN COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2012-12-20 | — | — | US | claimed |
| CN-1136588-A | Method for preparing alkali-free transparent soap block without alkalization | NANNANXI ENTERPRISE CO LTD (CN) | 1996-11-27 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140056953-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | SLC27A1, SLC27A2, FABP2 | NOD1 3906/4885PLA2G2C 809/4885PLA2G10 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.